Myriad Genetics (MYGN), Tufts Health Plan Enter Three-Year Contract for Prolaris
Tweet Send to a Friend
Myriad Genetics (NASDAQ: MYGN) announced that it has signed a three-year contract with Tufts Health Plan through which the plan ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
